The United States Patent and Trademark Office (USPTO) has recorded an intent-to-use trademark application for the mark VYLIBRA AX, identified by application number TM99492424. The application, filed on November 12, 2025, specifies its intended use in connection with oral contraceptives.

This filing signifies a preliminary step in the trademark registration process, indicating the applicant's future intention to use the mark commercially. While this is not a final registration, it establishes a priority date for the mark. Companies in the pharmaceutical sector should be aware of new trademark filings that may pertain to their product categories.